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Figure 4.INFγ
ELISpot confirmed
an increased
antigen specific Tcell response with
the Neu/IGFIR/IGFBP-2 peptide
vaccine. However,
Vitamin E showed
no significant
difference.
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Figure 1. Dendritic cell antigen uptake
measured in BALB/C mice via flow
cytometry demonstrates that the
addition of VE can increase dendritic
cell uptake. Vaccine: 4T1-GFP.
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Figure 3. Pilot
test revealed
that dendritic
cells are
required for Tcell activation.
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• Most cancer vaccines that seek to enhance
immune surveillance do not induce effective
responses in all patients, especially in poorly
immunogenic cancers such as estrogen
receptor negative breast cancer.
• One strategy to increase their efficacy is to
enhance antigen uptake and presentation by
dendritic cells, which are critical to adaptive
immunity and the function of these vaccines.
• Previous research has demonstrated that
Vitamin E (VitE) can increase dendritic cell
activity & therefore has the potential to aid in
enhancing the antigen uptake of dendritic
cells.
• Hypothesis: Vitamin E can act as an
immunologic adjuvant when administered
alongside cancer vaccines and can enhance
dendritic cell immunity and anti-tumor
immune response.

Figure 2. Analysis of Tcell response by
Carboxyfluorescein
succinimidyl ester
(CFSE) assay using
flow cytometry
revealed that tumor
infiltrating T-cell
proliferation increased
slightly when the
vaccines were
supplemented with
Vitamin E. C57BL/6
mice were utilized, and
each group had n=2.
Vaccine injections
consisted of 1m
E0771-GMCSF and
were given on day 0
and 7. The tumors
were collected on day
12.

• Vitamin E administered alongside cancer
vaccines showed increased dendritic cells
antigen uptake in ER negative breast
cancer models.
• Found a slight increase in antigen-specific
T-cell responses when cancer vaccines
were administered with Vitamin E. Future
research should repeat this data.

Acknowledgments
I would like to thank Dr. Yu for welcoming me
into her lab and providing me with guidance
throughout the project. I would also like to
thank Dr. Yi Xiao, who provided his expertise in
experimental design and writing. Lastly, I would
like to thank Dr. Yuan Zhang for being such a
kind, helpful, and hardworking mentor.

References
Hu HG, Li YM. Emerging Adjuvants for Cancer
Immunotherapy. Front Chem. 2020;8:601. Published 2020
Jul 30. doi:10.3389/fchem.2020.00601
Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E
in the immune system and inflammation. IUBMB Life.
2019;71(4):487-494. doi:10.1002/iub.1976

